Business Development Head - Human Vaccines

EVA Pharma

Strategy & Partnerships:

o Develop and execute a market entry strategy for technology transfer (fill-finish) in Egypt, North Africa, and Sub-Saharan Africa.

o Identify, negotiate, and secure partnerships with global vaccine innovators, CDMOs, and government bodies (e.g., Africa CDC, ministries of health).

Product Portfolio Strategy:

o Evaluate and recommend human vaccine products for technology transfer based on:

* Public health needs and disease burden per region

* Manufacturing feasibility and scalability

* Commercial viability and funding landscape

* Regulatory pathway complexity

o Prioritize vaccine candidates (e.g., routine immunization vs. pandemic-prevention vaccines).

Technology Transfer Leadership:

o Lead end-to-end technology transfer projects for human vaccines, including process validation and regulatory alignment.

o Collaborate with R&D, manufacturing, and quality teams to ensure scalable local production.

Market Expansion:

o Analyze market dynamics, funding opportunities (e.g., GAVI), and competitor landscapes to prioritize target markets.

o Build relationships with key stakeholders (WHO, Africa Union, local manufacturers).

Deal Execution:

o Structure licensing agreements, joint ventures, and co-manufacturing deals; oversee contract lifecycle management.

Cross-functional Collaboration:

o Align with regulatory affairs to navigate specific requirements.

o Support funding proposals for technology transfer initiatives.